• High throughput and reliable amplification for routine applications, screening or high-throughput screening • Amplification jusqu'à 5 kb, compatible avec le TA-cloning et l'incorporation de dUTP • 5' -> 3' exonuclease activity and absence of 3'-> 5' exonuclease activity
• Inactivated at room temperature, activation at 95°C for 15 min • Incorporation possible de dUTP • High specificity and sensitivity for high performance • Pour détection de cibles même en faible quantité, le screening, le mutliplexage, la PCR directe sur colonies, et les applications de qPCR
• Recombinant protein, ultrapure, at an initial concentration of 5 U/µl • Conserved 5'-'3' exonuclease activity and absence of 3'-'5' exonuclease activity • Adds a free adenine to the 3' end of the amplicon (monoadenylation) • Kit with 3 different 10X reaction buffers: without MgCl₂ (A), with MgCl₂ (B), with 2 inert dyes for direct deposit (C) • Kit supplied with dNTPs (separate tube)
• Recombinant protein, ultrapure, at an initial concentration of 1 U/µl • Contains 2 inert dyes (red and yellow) to facilitate PCR preparation and allow direct deposition on electrophoresis gel and migration monitoring • Conserved 5'-'3' exonuclease activity and absence of 3'-'5' exonuclease activity • Adds a free adenine to the 3' end of the amplicon (monoadenylation) • Kit with 2 different 10X reaction buffers: without MgCl₂ (A) and with MgCl₂ (B) • Kit supplied with dNTPs (separate tube)
Taq DNA Polymerase (cloned): 1 unit incorporates 10 nmol of total nucleotides into acid-insoluble material in 30 min at 70ºC, in a total volume of 50 µl.
The RTG (Ready-To-Go) is to provide the mix necessary for the reaction as preformulated, premixed, predispensed beads
• Increased reproducibility • Minimized pipetting steps • Reduced the potential for contamination • Long-term ambient-temperature stable (> 12 months)
Illustra Hot Start Mix RTG beads: for PCR requiring high amplification specificity. The only reagents to be added are water, the DNA to amplify and the primers.
Polymerase Chain Reaction (PCR) is covered by patents held by Roche Molecular Systems and F Hoffmann-La Roche Ltd.